This strategy enhanced antigen presentation and T cell priming, with significantly increased intratumoral infiltration of CD8+ T cells and dendritic cells, and therefore activated effector pathways including IFN‐γ and Granzyme B for tumor suppression (Figure 2c). The gene discussed is IFNG; the disease is neoplasm.